Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance

GlobeNewswire Inc. | Sep 23, 2026 8:45 AM EDT

Canadian clearance supports site activation and enrollment in the global study of once-daily oral PALI-2108